HIGH-THROUGHPUT, MASSIVELY PARALLEL DNA SEQUENCING TECHNOLOGY FOR THE ERA OF PERSONALIZED MEDICINE

2007 ◽  
Vol 03 (01) ◽  
pp. 15-31 ◽  
Author(s):  
JOHN H. LEAMON ◽  
MICHAEL S. BRAVERMAN ◽  
JONATHAN M. ROTHBERG
2018 ◽  
Vol 138 (10) ◽  
pp. 865-870 ◽  
Author(s):  
Yanfei Wang ◽  
Yu Lu ◽  
Jing Cheng ◽  
Lei Zhang ◽  
Dongyi Han ◽  
...  

Blood ◽  
2014 ◽  
Vol 124 (3) ◽  
pp. 453-462 ◽  
Author(s):  
Mohini Rajasagi ◽  
Sachet A. Shukla ◽  
Edward F. Fritsch ◽  
Derin B. Keskin ◽  
David DeLuca ◽  
...  

Key Points Tumor neoantigens are a promising class of immunogens based on exquisite tumor specificity and the lack of central tolerance against them. Massively parallel DNA sequencing with class I prediction enables systematic identification of tumor neoepitopes (including from CLL).


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Hiroki Miyajima ◽  
Hideaki Moteki ◽  
Timothy Day ◽  
Shin-ya Nishio ◽  
Takaaki Murata ◽  
...  

Nature ◽  
2008 ◽  
Vol 452 (7189) ◽  
pp. 872-876 ◽  
Author(s):  
David A. Wheeler ◽  
Maithreyan Srinivasan ◽  
Michael Egholm ◽  
Yufeng Shen ◽  
Lei Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document